The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clinical Observation on Treatment of 34 Advanced Gastric Carcinoma Patients by Chemotherapy of DCF Regimen Combined with Fuzheng Hewei Decoction
Author(s): 
Pages: 927-929
Year: Issue:  10
Journal: CHINESE JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE

Keyword:  中西医结合扶正和胃汤化疗进展期胃癌;
Abstract: 目的 观察中西医结合治疗进展期胃癌的疗效和不良反应.方法 将66例进展期胃癌患者随机分成两组.治疗组34例用中药加DCF方案化疗,对照组32例单纯用DCF方案化疗.结果 治疗组和对照组有效率分别为55.9%和50.0%,临床受益率分别为85.3%和81.3%,均无统计学差异;半年生存率:治疗组为82.4%,对照组为65.6%,两组比较无显著性差异(P>0.05);1年生存率:治疗组为52.9%,对照组为25.0%,两组结果有显著性差异(P<0.05).两组不良反应:WBC下降、恶心呕吐、黏膜反应、乏力有差异性(P<0.05).结论 中西医结合治疗进展期胃癌虽未能明显改善近期疗效,但能减轻不良反应,改善患者生活质量,延长患者生存期.
Related Articles
loading...